This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liassine, N.
Right arrow Articles by Auckenthaler, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liassine, N.
Right arrow Articles by Auckenthaler, R.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2002, p. 216-219, Vol. 46, No. 1
0066-4804/01/$04.00+0     DOI: 10.1128/AAC.46.1.216-219.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Postneurosurgical Meningitis Due to Proteus penneri with Selection of a Ceftriaxone-Resistant Isolate: Analysis of Chromosomal Class A ß-Lactamase HugA and its LysR-Type Regulatory Protein HugR

Nadia Liassine,1* Stéphanie Madec,2 Béatrice Ninet,1 Catherine Metral,1 Martine Fouchereau-Peron,3 Roger Labia,2 and Raymond Auckenthaler1

Central Laboratory of Bacteriology, University Hospital, Geneva, Switzerland,1 Centre National de la Recherche Scientifique, Unité FRE 2125, Quimper,2 Centre de Biologie Marine, Unité FRE 2125, Concarneau, France3

Received 30 January 2001/ Returned for modification 29 May 2001/ Accepted 29 September 2001


arrow
ABSTRACT
 
We report on a case of a postneurosurgical meningitis due to ceftriaxone-susceptible Proteus penneri, with selection of a ceftriaxone-resistant isolate following treatment with ceftriaxone. The isolates presented identical patterns by pulsed-field gel electrophoresis and produced a single ß-lactamase named HugA with an isoelectric point of 6.7. The ceftriaxone-resistant isolate hyperproduced the ß-lactamase (increase in the level of production, about 90-fold). The sequences of the hugA ß-lactamase gene and its regulator, hugR, were identical in both P. penneri strains and had 85.96% homology with those of Proteus vulgaris. The HugA ß-lactamase belongs to molecular class A, and the transcriptional regulator HugR belongs to the LysR family.


arrow
TEXT
 
The clinical significance of Proteus penneri, described in 1982 as a new species (9) and previously known as Proteus vulgaris indole negative, is poorly documented (13, 17). Like P. vulgaris, P. penneri is naturally resistant to ampicillin, narrow-spectrum cephalosporins, and cefuroxime by the production of a ß-lactamase commonly named cefuroximase (7, 15, 16). Only the ß-lactamase of P. vulgaris has been sequenced and characterized (6, 11). Named CumA (6), it belongs to molecular class A and functional group 2 e (4) of the ß-lactamases and is regulated by a system common to class C of the ß-lactamases (6, 11).

We report on a postneurosurgical infection due to P. penneri complicated by the emergence of a ceftriaxone-resistant isolate during treatment with ceftriaxone. Our purpose was to characterize the isolates of P. penneri and to understand the emergence of a ceftriaxone-resistant isolate of P. penneri by sequencing the ß-lactamase gene and its regulator.

Case report. After a severe cranial trauma, a reconstruction of the frontal and cranial basis with a muscular homograft and prosthetic material was performed in a 34-year-old patient. Four days later, because of suspected bronchopneumonia while the patient was under ventilation, a bronchoalveolar lavage (BAL) showed the presence of Staphylococcus aureus at 105 CFU/ml and P. penneri (isolate S08) at 104 CFU/ml. The bronchopneumonia resolved spontaneously. At day 22 a cerebral computed tomography scan followed by neurosurgical intervention showed a basal frontal breach and a cerebral abscess containing a pure culture of P. penneri (isolate S29) susceptible to ceftriaxone. Treatment with ceftriaxone (2 g twice a day [b.i.d.]), amikacin (500 mg b.i.d.), and metronidazole was instituted. Twelve days later, a P. penneri strain resistant to ceftriaxone (isolate R15) was isolated from the cerebrospinal fluid (CSF). A third neurosurgical intervention showed a frontal epidural infection and osteomyelitis due to a P. penneri strain resistant to ceftriaxone. With treatment with imipenem (500 mg four times a day) and gentamicin (120 mg b.i.d.) for 6 weeks, the patient healed without neurologic sequelae.

The isolates (S08 from BAL fluid, S29 and R15 from CSF) were identified as P. penneri with the API Rapid ID 32E gallery (bioMérieux, Marcy l’Etoile, France). They showed completely identical banding patterns by molecular typing, performed by pulsed-field gel electrophoresis after digestion with SfiI and NotI (New England Biolabs, Beverly, Mass.).

The results of antimicrobial susceptibility testing, performed according to the guidelines of NCCLS (18), are reported in Table 1. The isolate from CSF, P. penneri R15, was resistant to ceftriaxone; and synergy between the amoxicillin-clavulanic acid disk and the ceftriaxone disk and/or the cefepime disk was presented for this isolate, whereas such synergy was not found for isolate P. penneri S29, susceptible to ceftriaxone. According Le Comité de l’Antibiogramme of the French Society for Microbiology (1), this pattern of synergy for P. penneri suggests hyperproduction of a ß-lactamase instead of production of an extended-spectrum ß-lactamase.


View this table:
[in this window]
[in a new window]
  		TABLE 1. MICs for two isolates of P. penneri, S29 and R15

Specific activities of ß-lactamase. Bacterial strains were obtained from 4-liter cultures grown in brain heart infusion broth. Cells were harvested by centrifugation at 5,800 x g for 30 min. The pellets (about 12 g [wet weight]) were washed by resuspension in 24 ml of a 0.1 M NaCl solution and centrifuged as described above, and the supernatant was discarded. Then the pellets were resuspended in 24 ml of the same solution and lysed by ultrasonic treatment. The crude extracts were cleared by centrifugation at 48,000 x g for 30 min at 4°C. These extracts were used for specific activity determinations by computerized microacidimetry (14). P. penneri S29 and R15 both produced a single ß-lactamase of pI 6.7, as determined by analytical isoelectric focusing, but the ß-lactamases had different specific activities (2). These activities were determined with cephalothin as the substrate for crude extracts. The resistant strain increased its level of ß-lactamase production 91-fold compared with that for the susceptible strain, with production of 8.5 ± 1 and 0.093 ± 0.01 U/mg, respectively. The kinetic parameters of the highly purified (>97%) ß-lactamase from P. penneri R15 (Table 2) showed high degrees of activity for most cephalosporins, with kcat values ranging from 376 s-1 for cefamandole to 65 s-1 for ceftriaxone. The level of hydrolysis of ceftazidime was very low (0.5 s-1), a value comparable to that for ticarcillin. The enzyme was inhibited by clavulanic acid and tazobactam, with Ki values of 0.15 and 0.12 µM, respectively. In terms of kcat/Km values, cephalothin appears to be the best substrate and ceftriaxone is hydrolyzed about two times more rapidly than cefotaxime.


View this table:
[in this window]
[in a new window]
  		TABLE 2. Kinetic parameters for the ß-lactamase purified from P. penneri R15 and P. vulgaris Ro104

Sequencing of the ß-lactamase. The DNAs of P. penneri S29 and R15 were extracted by mechanical lysis and amplified with five pairs of primers chosen according to the sequences of the ß-lactamase gene of P. vulgaris (cumA gene) and its transcriptional regulator gene (cumR gene) (6) (pair 1, 5'-GTCAACTCGTGAAGGGAA-3' and 5'-TTTTTGACTCCTCACGTT-3'; pair 2, 5'-AGCGCTTCATTCATTAGCCAT-3' and 5'-TGAAGCTTCAGCAAGGCACCT-3'; pair 3, 5'-CGATCTTCTAACATCCTC-3' and 5'-AAGCTCACTTAATTGCGC-3'; pair 4, 5'-TATGAGCAACAATGACTATG-3' and 5'-ACCACTGCCAGTTTTATC-3'; pair 5, 5'-TCAAGCATTAACATTAGG-3' and 5'-TATTTTGTTTGAGGTGAA-3'). Three independent PCR products from each amplification were then analyzed by direct cycle sequencing with ABI dye terminator TaqFSkit (Applied Biosystems, Rotkreuz, Switzerland) and the ABI 373A apparatus (Applied Biosystems). Both strands of DNA were sequenced. The sequences coding for the ß-lactamase, named HugA, and an LysR-type regulator, named HugR, were identical in the susceptible and the resistant isolates (Fig. 1). The gene sequences had 85.96% homology with those of P. vulgaris. The deduced amino acid sequence of the ß-lactamases of the two isolates of P. penneri showed structural features typical of a class A ß-lactamase (12): active-site serine S*-T-S-K and its limiting elements S-D-N, E-P-E-L-N, and K-T-G. A serine was present at position 237 (21). The protein alignments of ß-lactamase HugA of P. penneri and the CumA ß-lactamase of P. vulgaris (6) showed great similarities, with 282 of 298 (94.6%) residues being identical.



View larger version (73K):
[in this window]
[in a new window]
  		FIG. 1. DNA sequence and translation of the ß-lactamase gene hugA and its regulator, hugR. The start codons and the beginnings of proteins are indicated by arrows, and the stop codons are indicated by asterisks. The -35 and -10 promoter sequences of ß-lactamase are underlined, whereas those of the regulator are in capital letters. A 31-base activator is indicated; it contains two inverted sequences, identified by the two pairs of arrowheads (<<<< and >>>>). Sequences are similar to those noticed by Ishiguro and Sugimoto (11).

The cerebral infection due to P. penneri described here is, to our knowledge, the first to be described and emphasizes the virulence (20) and the opportunistic character of P. penneri (18). The microorganism invaded the brain from the respiratory tract through a breach of the cranial basis. The interest of the present case is understanding of the emergence of a ß-lactamase-hyperproducing mutant of P. penneri during treatment with ceftriaxone. The HugA ß-lactamase of P. penneri, sequenced for the first time in the present study, belongs to structural class A of the ß-lactamases and was regulated by an equivalent of the amp system, a regulation system of class C ß-lactamases (15). The ampR gene encodes a transcriptional regulator, like hugR for P. penneri and cumR for P. vulgaris, whereas ampD encodes an enzyme that controls the induction of the ß-lactamase (3, 10). A mutation of the ampD gene results in high-level constitutive expression of the ß-lactamase and resistance to broad-spectrum cephalosporins. These mutants can be selected in vivo (5, 15). In the present case, both the ß-lactamase and transcriptional regulator genes of the ceftriaxone-susceptible isolate and the ceftriaxone-resistant isolate of P. penneri have similar sequences. This indicates that the ceftriaxone resistance is linked to a mutation elsewhere within the amp system and probably involves a mutation of the equivalent of the ampD gene in P. penneri. Previously, Datz et al. (6) restored the ceftriaxone susceptibility of a ceftriaxone-resistant isolate of P. vulgaris by introducing an ampD gene. In the present case, the selection of a ß-lactamase-hyperproducing mutant could be explained by several factors: (i) the cerebral localization of the infection, in which the concentration of ceftriaxone (8) is not sufficient to inhibit the growth of mutants; (ii) the presence of a prosthetic material, which allowed the adherence of microorganisms; and (iii) the large bacterial inoculum, which at the beginning contained a certain proportion of ß-lactamase-hyperproducing mutants. The present case emphasizes the necessity to carefully prescribe extended-spectrum cephalosporins as monotherapy for the treatment of severe infections due to P. penneri.

Nucleotide sequence accession number. The sequence coding for the ß-lactamase, named HugA, and a LysR-type regulator, named HugR, can be found in the GenBank database under accession number AF324468.


arrow
ACKNOWLEDGMENTS
 
We thank Wladimir Sougakoff for determination of the isoelectric point of the ß-lactamase, Reno Frei for the typing of isolates by pulsed-field gel electrophoresis, and Isabelle Jan for technical assistance.


arrow
FOOTNOTES
 
* Corresponding author. Present address: Laboratoire Bioanalytique-Riotton, 53 avenue Blanc, 1211 Geneva 2, Switzerland. Phone: (41) (22) 716 20 04. Fax: (41) (22) 716 20 07. E-mail: nliassine{at}unilabs.ch. Back


arrow
REFERENCES
 
    1
  1. Antibiogram Committee of the French Society for Microbioloy. 1998. Statement. Pathol. Biol. 8:I–XVI.
    2. 2
  2. Barthelemy, M., M. Guionie, and R. Labia. 1978. Beta-lactamases: determination of their isoelectric points. Antimicrob. Agents Chemother. 13:695–698.[Abstract/Free Full Text]
    3. 3
  3. Bennett, P. M., and I. Chopra. 1993. Molecular basis of ß-lactamase induction in bacteria. Antimicrob. Agents Chemother. 37:153–158.[Free Full Text]
    4. 4
  4. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for ß-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211–1233.[Medline]
    5. 5
  5. Chow, J. W., M. J. Fine, D. M. Shlaes, J. P. Quinn, D. C. Hooper, M. P. Johnson, R. Ramphal, M. M. Wagener, D. K. Miyashiro, and V. L. Yu. 1991. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann. Intern. Med. 115:585–590.
    6. 6
  6. Datz, M., B. Joris, E. A. M. Azab, M. Galleni, J. Van Beeumen, J. M. Frère, and H. H. Martin. 1994. A common system controls the induction of very different genes, the class-A ß-lactamase of Proteus vulgaris and the enterobacterial class-C ß-lactamase. Eur. J. Biochem. 226:149–157.[Medline]
    7. 7
  7. Grace, M. E., F. J. Gregory, P. P. Hung, and K. P. Fu. 1986. Purification and properties of a ß-lactamase from Proteus penneri. J. Antibiot. 39:938–942.[Medline]
    8. 8
  8. Granero, L., M. Santiago, J. Cano, A. Machado, and J. E. Peris. 1995. Analysis of ceftriaxone and ceftazidime distribution in cerebrospinal fluid of and cerebral extracellular space in awake rats by in vivo microdialysis. Antimicrob. Agents Chemother. 39:2728–2731.[Abstract]
    9. 9
  9. Hickman, F. W., A. G. Steigerwalt, J. J. Farmer III, and D. J. Brenner. 1982. Identification of Proteus penneri sp. nov., formerly known as Proteus vulgaris indole negative or as Proteus vulgaris biogroup 1. J. Clin. Microbiol. 15:1097–1102.[Abstract/Free Full Text]
    10. 10
  10. Honoré, M., M. H. Nicolas, and S. T. Cole. 1989. Regulation of enterobacterial cephalosporinase production: the role of a membrane-bound sensory transducer. Mol. Microbiol. 3:1121–1130.[CrossRef][Medline]
    11. 11
  11. Ishiguro, K., and K. Sugimoto. 1996. Purification and characterization of the Proteus vulgaris BlaA protein, the activator of the ß-lactamase gene. J. Biochem. 120:98–103.[Abstract/Free Full Text]
    12. 12
  12. Joris, B., P. Ledent, O. Dideberg, E. Fonzé, J. Lamotte-Brasseur, J. A. Kelly, J. M. Ghuysen, and J. M. Frère. 1991. Comparison of the sequences of class A ß-lactamases and of the secondary structure elements of penicillin-recognizing proteins. Antimicrob. Agents Chemother. 35:2294–2301.[Abstract/Free Full Text]
    13. 13
  13. Krajden, S., M. Fuksa, C. Petrea, L. J. Crisp, and J. L. Penner. 1987. Expanded clinical spectrum of infections caused by Proteus penneri. J. Clin. Microbiol. 25:578–579.[Abstract/Free Full Text]
    14. 14
  14. Labia, R., J. Andrillon, and F. Le Goffic. 1973. Computerized microacidimetric determination of a ß-lactamase Michaelis Menten constants. FEBS Lett. 33:42–44.[CrossRef][Medline]
    15. 15
  15. Livermore, D. M. 1995. ß-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557–584.[Abstract]
    16. 16
  16. Miro, E., M. Barthélémy, J. Péduzzi, A. Reynaud, A. Morand, G. Prats, and R. Labia. 1994. Propriétés d’une céphalosporinase de Proteus penneri inhibée par l’acide clavulanique. Pathol. Biol. 42:487–490.[Medline]
    17. 17
  17. Mohr O’Hara, C., F. W. Brenner, and J. M. Miller. 2000. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin. Microbiol. Rev. 13:534–546.[Abstract/Free Full Text]
    18. 18
  18. National Committee for Clinical Laboratory Standards. 1999. Performance standards for antimicrobial susceptibility testing; ninth information supplement. M100S9, vol. 19, no. 1. National Committee for Clinical Laboratory Standards, Wayne, Pa.
    19. 19
  19. Peduzzi, J., A. Reynaud, P. Baron, M. Barthélémy, and R. Labia. 1994. Chromosomally encoded cephalosporinase of Proteus vulgaris Ro104 belongs to Ambler’s class A. Biochim. Biophys. Acta 1207:31–39.[CrossRef][Medline]
    20. 20
  20. Rozalski, A., Z. Sidorczyk, and K. Kotelko. 1997. Potential virulence factors of Proteus bacilli. Microbiol. Mol. Biol. Rev. 61:65–89.[Abstract]
    21. 21
  21. Tamaki, M., M. Nukaga, and T. Sawai. 1994. Replacement of serine 237 in class A ß-lactamase of Proteus vulgaris modifies its unique substrate specificity. Biochemistry 33:1020–1026.

Antimicrobial Agents and Chemotherapy, January 2002, p. 216-219, Vol. 46, No. 1
0066-4804/01/$04.00+0     DOI: 10.1128/AAC.46.1.216-219.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Jacoby, G. A. (2009). AmpC {beta}-Lactamases. Clin. Microbiol. Rev. 22: 161-182 [Abstract] [Full Text]  
  • Jacoby, G. A. (2006). {beta}-Lactamase Nomenclature.. Antimicrob. Agents Chemother. 50: 1123-1129 [Full Text]  
  • Walckenaer, E., Poirel, L., Leflon-Guibout, V., Nordmann, P., Nicolas-Chanoine, M.-H. (2004). Genetic and Biochemical Characterization of the Chromosomal Class A {beta}-Lactamases of Raoultella (formerly Klebsiella) planticola and Raoultella ornithinolytica. Antimicrob. Agents Chemother. 48: 305-312 [Abstract] [Full Text]  
  • Vimont, S., Poirel, L., Naas, T., Nordmann, P. (2002). Identification of a Chromosome-Borne Expanded-Spectrum Class A {beta}-Lactamase from Erwinia persicina. Antimicrob. Agents Chemother. 46: 3401-3405 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liassine, N.
Right arrow Articles by Auckenthaler, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liassine, N.
Right arrow Articles by Auckenthaler, R.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»